Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
Autor: | Chang Lu, Shuai Peng, Jincheng Wang, Qing Ke, Jing-Jing Chai, Xinzhou Deng, Zelin Xu |
---|---|
Rok vydání: | 2021 |
Předmět: |
0301 basic medicine
Cancer Research Cell cisplatin P-glycoprotein emodin Flow cytometry 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine medicine non-small cell lung cancer Cisplatin medicine.diagnostic_test biology Chemistry Cell growth Articles Cell cycle respiratory tract diseases chemosensitivity 030104 developmental biology medicine.anatomical_structure Oncology Apoptosis 030220 oncology & carcinogenesis Cancer research biology.protein Emodin medicine.drug |
Zdroj: | Oncology Letters |
ISSN: | 1792-1082 1792-1074 |
Popis: | Cisplatin resistance is one of the main causes of chemotherapy failure and tumor progression in non-small cell lung cancer (NSCLC). Emodin has been demonstrated to induce NSCLC cell apoptosis and act as a potential cancer therapeutic agent. However, whether emodin could affect NSCLC cell sensitivity toward cisplatin remains unclear. The present study aimed to determine the effect of emodin and cisplatin combination on the chemosensitivity of NSCLC cells. A549 and H460 cells were treated with different concentrations of cisplatin and/or emodin. Cell Counting Kit-8, fluorescence microscopy, immunofluorescence assays and flow cytometry were used to determine cell proliferation, drug efflux, DNA damage level and cell apoptosis, respectively. P-glycoprotein (Pgp) and multidrug resistance-associated protein 1 (MRP1) expression was detected by western blotting. The results demonstrated that emodin and cisplatin inhibited the proliferation of A549 and H460 cells. Furthermore, emodin inhibited the drug efflux in A549 and H460 cells in a dose-dependent manner. In addition, emodin enhanced cisplatin-induced apoptosis and DNA damage in A549 and H460 cells. Emodin also decreased Pgp expression in A549 and H460 cells in a dose-dependent manner; however, it had no effect on MRP1 expression. Taken together, the results from the present study demonstrated that emodin can increase A549 and H460 cell sensitivity to cisplatin by inhibiting Pgp expression. Emodin may therefore be considered as an effective adjuvant for cisplatin treatment. |
Databáze: | OpenAIRE |
Externí odkaz: |